What Can You Expect at the Premier RAS Forum in 2026?
With RAS now one of oncology’s most competitive targets, the race is on to deliver durable and broadly effective therapies. The 8th RAS-Targeted Drug Development Summit unites industry pioneers to share cutting-edge data, emerging modalities, and actionable development strategies. Expect expert-led sessions, practical case studies, and meaningful networking designed to help you overcome resistance, optimize combinations, and advance next-generation RAS programmes faster.
Unmissable Event Highlights
Advance Clinically Effective RAS Combination Strategies
Explore frameworks for prioritizing combinations that balance biological rationale, safety, and real-world feasibility across tumor types while addressing resistance and expanding therapeutic reach with case studies from Cardiff Oncology, Vividion Therapeutics, Incyte and Amgen.
Shape the Next Generation of KRAS-Mutant Therapies
Explore how Bristol Myers Squibb, BeOne Medicines, and Revolution Medicines are advancing selective and wild-type-sparing approaches, tri-complex RAS(ON) inhibitors, and multi-agent regimens that balance potency with tolerability. Discover how PK/PD-guided dosing and mechanism-based safety strategies are enabling deeper, longer-lasting RAS inhibition.
Expand Therapeutic Strategies Beyond Small Molecules
Discover how Elicio Therapeutics, Anocca, Aston Sci, and Silexion Therapeutics are advancing oncology through mRNA vaccines, TCR-T therapies, and RNAi approaches that activate durable anti-tumor immunity, silence KRAS, broaden patient eligibility, and overcome resistance. Gain insights into designing next-generation immunotherapies that complement conventional treatment strategies.
Unlock the Potential of Pan-KRAS Targeting
Gain insight into how BlossomHill Therapeutics, NCI, Ensem Therapeutics, and Oncogenuity are transforming pan-KRAS targeting through dual ON/OFF engagement, targeted degradation, and oligonucleotide technologies that overcome resistance and enable safer, more durable therapies.
Explore the Full Event Guide
- Get the full agenda at a glance – including session details and focus day content
- See the complete speaker faculty – all experts, titles, and organisations in one place
- Understand the key scientific themes - from next generation inhibitors, to panRAS approaches & novel modalities
- Preview who you’ll meet – attendee profiles, company types, and networking formats
- Explore partnership and registration options - including pricing, deadlines, discounts, and opportunities to showcase solutions
Attending Companies Included
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.